McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
711.82
+1.63 (0.23%)
At close: Jul 25, 2025, 4:00 PM
713.49
+1.67 (0.23%)
After-hours: Jul 25, 2025, 7:44 PM EDT
McKesson Revenue
In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth. McKesson had revenue of $90.82B in the quarter ending March 31, 2025, with 18.95% growth.
Revenue (ttm)
$359.05B
Revenue Growth
+16.22%
P/S Ratio
0.25
Revenue / Employee
$7,040,216
Employees
51,000
Market Cap
89.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MCK News
- 7 hours ago - McKesson Defied The Doubters (Including Me)--And Could Do It Again - Seeking Alpha
- 7 days ago - Our Top 10 High Growth Dividend Stocks - July 2025 - Seeking Alpha
- 11 days ago - McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Business Wire
- 4 weeks ago - McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date - Business Wire
- 5 weeks ago - Our Top 10 High Growth Dividend Stocks - June 2025 - Seeking Alpha
- 5 weeks ago - 20 companies in the S&P 500 whose investors have gained the greatest rewards from stock buybacks - Market Watch
- 6 weeks ago - McKesson to Host Investor Day on September 23, 2025 - Business Wire
- 7 weeks ago - McKesson Corporation Completes Acquisition of Core Ventures - Business Wire